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Detection of Liver Fibrosis with Magnetic 
Cross-Relaxation 
Alex M. Aisen, Kei Doi, Scott D. Swanson 
The utility of MRI using magnetization transfer (MT) en- 
hanced pulse sequences to diagnose hepatic cirrhosis in a rat 
model was investigated. Hepatic T1 was measured with and 
without MT off-resonance RF pulses in 17 treated and six 
control rats. The livers were evaluated histologically, and the 
hydroxyproline content quantitatively measured. We did not 
find a statistically significant linear correlation between the 
MR relaxation times and the degree of tissue injury. However, 
the MR measurements performed with MT were superior to 
those without differentiating the treated and control groups. 
Specifically, the T, times were 695 * 76 ms for the treated 
group, versus 748 f 61 ms in the controls; P= 0.095. The T,,, 
times were also lower in the treated group, with statistical 
significance: 367 * 51 ms versus 421 i 38 ms, P = 0.016. 
Finally, the change in the relaxation rates (the inverse of the 
relaxation times) with and without saturation were 1.31 f 0.22 
s-' (treated group) versus 1.05 i 0.12 s-' (controls), which 
differed significantly, P = 0.001. 
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INTRODUCTION 
The specific identification of fibrosis is an important 
problem in imaging diagnosis. X-ray and ultrasound 
based imaging have not been able to make this differen- 
tiation; conventional MRI has also been disappointing 
The liver provides a useful organ for study. Clinically, 
many diseases are characterized by inflammation and 
edema which may progress to fibrotic scarring, or cirrho- 
sis. Diagnosis of cirrhotic change by noninvasive means 
would be valuable. Long-term administration of the sol- 
vent carbon tetrachloride to rats is known to produce a 
condition which in many ways mimics many human 
diseases (7). In earlier work using this model, Chamuleau 
et al. found that hepatic TI levels rose with liver injury, 
peaking at 4 weeks and maintaining this plateau; colla- 
gen levels reached their maximum at 8 weeks. They con- 
cluded that the TI increases represented edema, and were 
not useful for measuring fibrosis (2). 
Magnetization transfer contrast (MTC) is a technique 
where RF radiation is employed to selectively saturate 
the nuclear magnetism of immobile protons in mem- 
branes or macromolecules such as collagen (8-15). We 
(1-6). 
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investigated the use of MTC to determine if the technique 
might allow differentiation of tissue fibrosis from other 
pathology, and to assess its potential to quantify the 
amount of fibrous tissue present. 
The basic hypothesis of this work is that as the amount 
of solid material, specifically collagen, increases in the 
liver with chemically induced fibrosis, the cross relax- 
ation pathway will become a more dominant mechanism 
for TI in the tissue and shorten the measured TI in tissue. 
Observation of this phenomenon in the liver is compli- 
cated by edema, which also results from the carbon tet- 
rachloride treatment. Hepatic edema will act conversely 
to lengthen the measured TI. These competing effects 
complicate efforts to measure liver fibrosis with conven- 
tional MRI. 
Off-resonance RF irradiation selectively saturates the 
immobile proton magnetization of the tissue and indi- 
rectly, via magnetic cross relaxation, saturates the MRI 
detected, mobile proton magnetization (9, lo). In addi- 
tion, indirect RF saturation also decreases the apparent 
TI of the mobile proton magnetization to a value defined 
as TI,,, (8). It was our hope that measurement of these 
parameters before and after MTC irradiation would pro- 
vide specific information on the presence of cirrhosis. 
METHODS 
Treatment Protocol 
White Sprague-Dawley rats received a 3-week course of 
phenobarbital (to induce hepatic enzyme systems), fol- 
lowed by 14 weeks of administration of carbon tetrachlo- 
ride by NG tube. Following initial dosing with standard- 
ized quantities, subsequent doses of CC1, for each rat 
were individually determined based on the weight loss 
which followed previous doses, an approach described 
by Proctor and Chatamra (7). Twenty-five rats entered the 
treatment protocol, but only 17  completed it; these form 
the basis of this report. (Of the remaining eight animals, 
four died, three did not undergo post-mortem MRI evalu- 
ation; and in one rat there was a technical failure in the 
non-MTC MRI measurements). Six untreated rats served 
as controls for the MR experiments; however, these con- 
trol rats did not have histologic and biochemical evalu- 
ation. Histologic and biochemical measurements were 
made on a separate group of 10 untreated rats. 
MRI Measurements 
MRI was performed with a 2.0 T Omega CSI system 
(Omega software version 6.02) manufactured by Bruker 
Instruments (Fremont, CA) and equipped with S-180 ac- 
tively shield gradients. The RF probe for transmit and 
receive was a home-built saddle coil with an 8-cm diam- 
eter and 13-cm length. This probe provided sufficient RF 
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homogeneity and sensitivity for the rat liver studies pre- 
sented here. 
The control and treated animals were anaesthetized 
with ketamine and Rompain. The liver was located with 
a multislice T,-weighted imaging sequence. 
Measurements of T, and TI,,, were made using a single 
axial slice, 8-point, Look and Locker imaging pulse se- 
quence (16,17). Data was acquired both with and without 
MTC irradiation, consisting of a 530 Hz ( y B , / 2 5 ~ )  pulse 
applied 10 kHz off resonance during the relaxation delay 
periods of the sequence. The non-MTC and MTC meas- 
urements (the latter herein identified with the suffix 
“sat”) were made both in the living animals, and follow- 
ing sacrifice with anesthetic overdose. Respiratory gating 
or compensation was not used. The postsacrifice meas- 
urements are presented here. 
The slice-selective Look and Locker sequence is shown 
in Fig. 1. The magnetization is inverted by a composite 
180’ pulse and then sampled a series of by a small flip 
angle pulses. The measured relaxation rate will be greater 
than the true relaxation rate due to the sampling of the 
longitudinal magnetization by the pulse train. Therefore, 
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FIG. 1 .  Look and Locker imaging sequence for determination of 
TI and TI,,. Data from eight points along the relaxation curve with 
a spacing of 150 ms were collected for each phase encoding line 
with a TR of 2.7 s, a JEof 6.6 ms, a nominal flip angle a of l Y ,  a 
block size of 128 x 128, a slice thickness of 5 mm, a FOV of 60 
mm, and 2 averages. The MTC pulse was applied 10 kHz off- 
resonance with an amplitude y 6 , / 2 ~  of 530 Hz and a duration of 
123 ms for each of the eight relaxation delays. The duty cycle of 
off-resonance RF irradiation for the entire pulse sequence was 
36%. The duty cycle of RF irradiation during the collection of one 
phase encoding line was El%, with the remaining time used for 
frequency shifting and data collection. 
separation between the pulses and a is the flip angle, 
must be added to the measured relaxation rates to obtain 
the true relaxation rates. In the experiments performed 
here, a was nominally 15’ and T 150 ms, yielding a cor- 
rection factor of -0.23 s-l. T,,,, is determined with the 
off-resonance RF irradiation turned on during the recov- 
ery period. The following MRI parameters were calcu- 
lated: T,, Tlsat, their inverses (the relaxation rates R, and 
Rlsat), the difference of the relaxation rates, M,, MSat, and 
the ratio M,,,lM,. 
Calibration of RF power is critical for the success of 
this experimental protocol. Knowledge of a is required 
for the Look and Locker experiment and T,,,, is a function 
of the power of the off-resonance RF irradiation. To cali- 
brate the RF power for each experiment, a one-dimen- 
sional, spin-echo imaging sequence was used. Specifi- 
cally, the phase encode gradient was turned off and the 
power of the 6 and 2% pulses in the spin echo sequence 
varied to maximize the amplitude of the detected echo. 
The amount of power required to achieve flip angles of 
90’ and 180’ was determined and used to normalize the 
amplitude of the a and MTC pulses in the Look and 
Locker sequence over the course of this study. 
Since the sign of the magnetization changes from nega- 
tive to positive during the TI inversion-recovery experi- 
ment, it is desirable to process the data in a phase sensi- 
tive manner. To accomplish this, the following protocol 
was used. Each of the eight 128 X 128 raw k-space data- 
sets from an inversion-recovery imaging experiment was 
baseline corrected and Fourier transformed along both 
dimensions without taking the magnitude. The 8-phase 
sensitive images were then divided by the image from the 
initial time point and multiplied by -1. This process 
eliminates phase due to all sources except the inversion- 
recovery of magnetization and allows us to calculate T, 
and T,,, in a phase sensitive manner. A region-of-interest 
within the liver was chosen for analysis based on loca- 
tion and signal homogeneity, minimizing arefacts due to 
RF inhomogeneity and partial voluming. A representa- 
tive image is shown in Fig. 2. The signal within the ROI, 
nominally 400 pixels, was summed for each of the eight 
images and the resulting values used for the determina- 
tion of TI and TI,,. Inversion-recovery data and fitted 
results for T, and T,,, are shown in Fig. 3. 
At the conclusion of the experiments, the livers were 
removed from all treated and control animals. The organs 
were divided. Following a period of frozen storage, ob- 
jective, biochemical assays of hydroxyproline content 
were performed on one portion of the liver using a 
method previously described (18). The other portions of 
the organs were histologically graded on a scale of 0 
(normal) through 5 (severe fibrotic change) by an inde- 
pendent animal pathologist blinded to the NMR data. 
Photomicrographs of liver sections from normal and 
treated animals are shown in Figs. 4a and 4b, respec- 
tively. Wet weightldry weight was measured following 
vacuum desiccation of one of the portions of each liver. 
Data is expressed as mean ? standard deviations. Sta- 
tistical comparisons employed an unpaired, two-tailed 
Student’s t test with unequal variances; the standard for 
significance is P < 0.05. 
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FIG. 2. The eighth image (final time point) acquired with the Look 
and Locker pulse sequence shown in Fig. 1 with parameters as 
given in the legend to Fig. 1. Also shown is the ROI from which the 
data is obtained to produce the relaxation curves in Fig. 3. 
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FIG. 3. Data for determination of T1 and T,,, and fitted relaxation 
curves. The data for T, (A) and Tlsa, (0) were obtained by summing 
the signals within the ROI shown in Fig. 2. For this example, the 
estimates for Tl and T,, corrected for flip angle and delay time, 
are 731 ? 33 m s  and 350 2 17 ms, respectively. The relaxation 
curves for T, and T,,,, calculated with the parameters obtained by 
the fitting procedure, are indicated by the solid and dashed lines, 
respectively. 
RESULTS 
The presacrifice MR measurements showed considerable 
scatter when compared with the postmortem measure- 
ments. For this reason, final data analysis was performed 
on the postmortem MRI measurements only, as it was felt 
that the presacrifice measurements were degraded by in- 
accuracies resulting from respiratory motion. As noted 
above, normal values for hydroxyproline content, and 
histology were obtained in 10 rats; these are different 
b 
FIG. 4. Representative histological specimens (1 OOX) of liver 
sections from normal (a) and treated (b) animals; the treated ani- 
mal shown had severe disease, grade 5. 
animals from the six used for the MRI measurements and 
percent water determinations. 
The percent water by weight in the treated animals was 
79.7% ? 0.19%, versus 70.9% ? 2.5% in the six controls. 
The percent dry weight hydroxyproline content was 
higher in the treated group, 1.99 ? 0.81 mg/gm versus 
0.854 2 0.12 mg/g (P = 0.000003518). All untreated ani- 
mals were graded as normal histology; the average grade 
for the treated animals was 2.8 (5 being most severe). 
The corrected T, times for the treated animals were 
lower in the treated animals than the controls, though the 
difference was not significant: 695 ? 76 ms versus 748 ? 
61 ms; P = 0.095. The TI,,, times were also lower in the 
treated group, with statistical significance: 367 51 ms 
versus 421 ? 38 ms, P = 0.016. 
The change [i.e., difference) of the relaxation rates with 
and without saturation, 1.31 ? 0.22 s-l [treated group) 
versus 1.05 ? 0.12 s-l (controls), differed significantly, 
P = 0.001. The ratio of M,,,/M, differed between the two 
groups as well; 0.519 ? 0.029 for the treated animals 
versus 0.542 2 0.018 for the controls; P = 0.028. 
Linear correlations between the MRI parameters and 
the quantitative hydroxyproline content or histological 
grades were not revealing. 
Similar trends in the TI and T,,,, differences between 
554 Aisen et al. 
the groups were observed in the presacrifice data, but 
these did not reach statistical significance, presumably 
because of motion. 
such therapy. In pulmonary disease, it is often difficult to 
differentiate interstitial water or edema from fibrosis, 
though the two conditions have completely different im- 
plications and therapies. 
Presently, biopsy is considered the only reliable means 
of diagnosing fibrotic change, though serial biochemical DISCUSSION 
The histologic determinations revealed substantial varia- 
tion in the degree of fibrotic change. No statistically sig- 
nificant difference was found between the postsacrifice 
T, of a group of 17 treated animals and the T, of 6 control 
animals. However, the Tlsat measurements did show a 
significant difference between the treated group and the 
control group. Interestingly, a strong statistical differ- 
ence, P = 0.001, was found in the change in relaxation 
rates which occurred with application of MTC saturation 
(Lee, Rlsat - R,) when the treatment and control groups 
were compared. These results are encouraging, but by no 
means conclusive. By providing an additional mecha- 
nism for relaxation to occur, MTC irradiation is expected 
to shorten TI times; this effect will be most pronounced 
when there is a substantial amount of fibrosis tissue 
present. Our results are consistent with this. We had 
hoped to be able to use this effect to quantitate the 
amount of fibrous tissue present, but were unsuccessful: 
correlations of the relaxation parameters with the quan- 
titative measures of fibrosis in a pooled group including 
both treated and untreated animals was not revealing. We 
cannot tell whether this is a result of inaccuracies in our 
measurements or an intrinsic limitation of the MTC tech- 
nique. 
The data presented here describes post-mortem meas- 
urements obtained on both treated and control animals; 
data collected in living animals showed similar trends, 
but did not reach statistical significance. Perfusion has 
been shown to slightly alter MTC measurements (19). 
Thus, it is conceivable that alterations in blood perfusion 
in living animals with cirrhosis might affect measure- 
ments such as ours. This possibility could be investigated 
in future work. 
In contrast to Chamuleau et al., we found that the T,  
relaxation times in our treated animals decreased. The 
difference is almost certainly a result of the longer treat- 
ment period we used compared with Chamuleau; this 
would be expected to allow hepatic inflammation to 
progress from edema towards end-stage fibrotic cirrhosis. 
This is largely substantiated by our histologic and per- 
cent water data. Chamuleau et al. made their measure- 
ments on living animals using respiratory gating; our data 
are postmortem. 
The identification of fibrosis is an important clinical 
problem. In some cases, such as treated malignancies, it 
is necessary to differentiate recurrent or residual neo- 
plasm from fibrous scarring. In other conditions, such as 
Darenchvmal diseases of the liver and kidney, the pres- 
assays- of serum procollagen levels-have been proposed 
for liver disease (25). MR has been investigated as a po- 
tential tool for quantitatively assessing fibrosis, although 
the results have thus far been discouraging. As discussed 
earlier, Chamuleau et al. concluded that changes in T,  
times reflected edema, and were not useful for detecting 
fibrosis (2). Similarly, Goldberg et al. found no change in 
T, and T, times with thioacetamide induced cirrhosis in 
rats IS), and Rademaker et al. found no change in T,  
values in human patients with methotrexate-induced cir- 
rhosis (26). 
Data for the lung has been more promising, though by 
no means conclusive. Vinitski et al. documented de- 
creased T, and T,  values in lung samples obtained from 
rats following long-term bleomycin treatment (27). 
Shioya et al. documented a decrease in the T, (but not T,) 
time of lung tissue with late stage radiation induced fi- 
brosis in rats (1). Taylor et al. found an increase in T,, but 
no change in T,, in the lung in mice treated with bleo- 
mycin (3). Contrast agents may also be helpful (28). 
Imaging data has been reported in humans, with at- 
tempts to correlate appearance on T.-weighted images 
with fibrotic scarring, since fibrous tissue is felt to have a 
short T,  time. This has yielded very mixed results; most 
investigators find fibrous tissue to be dark on T,- 
weighted images (29-33), although the results are by no 
means always consistent; Negandank et al., for example, 
found that dense fibrosis in patients with histories of 
lymphoma was bright on T,-weighted images (5). 
Many (34-37), but not all (26, 38), studies suggest that 
MRI and contrast-enhanced MRI (39,40) may be of use in 
diagnosing diffuse hepatic disease, including hepatitis 
with edema; however, there is little evidence that con- 
ventional MRI is useful in diagnosing fibrotic change. 
Similarly, MR spectroscopy (41-43) techniques offer 
promise for characterization of liver disease, including 
impairment in hepatocellular function, but has not yet 
been shown to be specific for fibrosis. 
The data presented here is limited by the accuracy of 
the MR measurements, even though postmortem data 
free from motion artifact is used in the analysis. It seems 
likely that in vivo measurements will require an alterna- 
tive approach, which is more motion insensitive that our 
technique. One possibility is a spin-echo technique em- 
ploying column selection based on the intersection of 
orthogonal slice selective 90° and 180" pulses, with a 
read-out gradient applied along the column axis. 
CONCLUSION ence of fibrous tissue is usually an indicator of end-stage disease which is unlikely to respond to aggressive 
therapy, while the absence of fibrosis has opposite im- The results are encouraging but not conclusive. The in- 
plications. Pharmacological therapies are becoming crease in Rlsat for fibrotic livers was reliably seen only in 
available which may be able to retard or prevent fibrosis the data from the sacrificed animals and therefore motion 
(20-24); the early detection of fibrotic change, and the insensitive pulse sequences would probably be helpful to 
ability to monitor it over time seem crucial to the use of measure Rlsat in vivo. An increase in the R, relaxation rate 
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for fibrotic livers compared with control livers is consis- 
tent with an increase in the fraction of macromolecular 
protons (e.g., collagen). The relaxation rates measured 
here are, however, a complicated function of the many 
tissue constituents and the change seen is not necessarily 
due to the increased collagen levels. Nonetheless, this 
study suggests that R,,,, is sensitive to the solid content in 
tissue and may be helpful in the diagnosis of liver fibro- 
sis. 
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